---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-005334"
form_type: "8-K/A"
ticker: "SUIC"
cik: "0001394108"
company_name: "SUIC Worldwide Holdings Ltd."
filed_at: "2026-08-31T21:17:35+00:00"
generated_at: "2026-08-31T21:18:20.366859+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# SUIC Worldwide acquires 51% of Taiwan medical-device firm Vision Renu for 30M shares

## Summary
- SUIC issued 30M shares (35% fully diluted) to acquire 51% of Vision Renu; implied enterprise value $50M based on $0.85/share.
- New leadership: Chen King Te named Chairman/CEO, Kho Jean Jean CFO, Dongsheng Zou director; Lo, Wang, Tan resigned.
- Vision Renu products: presbyopia laser (FDA approval pending) and TMS depression device (Taiwan-approved); 150-unit 2026 orders.
- Pro forma 2025: combined revenue $163K, net loss attributable to SUIC $341K, EPS -$0.0082; goodwill $47.98M recorded.

## SEC filing metadata
- accession: 0001477932-26-005334
- form_type: 8-K/A
- ticker: SUIC
- cik: 0001394108
- company_name: SUIC Worldwide Holdings Ltd.
- filed_at: 2026-08-31T21:17:35+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 2.01, 5.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1394108/000147793226005334/0001477932-26-005334-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1394108/000147793226005334/suic_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-005334
- JSON: https://secwatch.observer/filing/0001477932-26-005334.json
- Plain text: https://secwatch.observer/filing/0001477932-26-005334.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.